Mycobacterial infectious diseases, including tuberculosis (TB), severely threaten global public health. Nonreplicating () is extremely difficult to eradicate using current TB drugs that primarily act on replicating cells. Novel TB drugs acting on unconventional targets are needed to combat TB efficiently.
View Article and Find Full Text PDF